News
2d
Zacks Investment Research on MSNAmgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales GrowthAmgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...
Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.
Diabetes is a lifelong battle for keeping your blood sugar levels in control. To do that effectively, you need to consume a ...
There were 26.4 deaths per 100,000 people from diabetes, according to early death certificate data for the third quarter of ...
Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results